Cargando…
IL-4 contributes to failure, and colludes with IL-10 to exacerbate Leishmania donovani infection following administration of a subcutaneous leishmanial antigen vaccine
BACKGROUND: Visceral leishmaniasis caused by the protozoan parasite Leishmania donovani complex is a potentially fatal disease if left untreated. Few treatment options exist and are toxic, costly and ineffective against resistant strains. Thus a safe and efficacious vaccine to combat this disease is...
Autores principales: | Bhowmick, Sudipta, Ravindran, Rajesh, Ali, Nahid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897895/ https://www.ncbi.nlm.nih.gov/pubmed/24428931 http://dx.doi.org/10.1186/1471-2180-14-8 |
Ejemplares similares
-
Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis
por: Ravindran, Rajesh, et al.
Publicado: (2010) -
Identification of Novel Leishmania donovani Antigens that Help Define Correlates of Vaccine-Mediated Protection in Visceral Leishmaniasis
por: Bhowmick, Sudipta, et al.
Publicado: (2009) -
Surface antigens of Leishmania donovani promastigotes
Publicado: (1983) -
Vaccine Development Against Leishmania donovani
por: Das, Amrita, et al.
Publicado: (2012) -
Secure Localization in the Presence of Colluders in WSNs
por: Shi, Wei, et al.
Publicado: (2017)